Treatment Market is set to acquire a value of USD 11,973.7 million in 2024. By 2034, the value of the psoriatic arthritis (PsA) treatment market is slated to shoot upwards of USD 25,375.6 million. As ...

MoonLake Immunotherapeutics' Sonelokimab's Phase 3 trials, PsA market growth, and Merck's $3B bid showcase potential. Read my ...

Newseria nie ponosi odpowiedzialności za treści oraz inne materiały (np. infografiki, zdjęcia) przekazywane w „Biurze Prasowym”, których autorami są zarejestrowani użytkownicy tacy jak agencje PR, ...

Metabolic syndrome is associated with elevated levels of pain catastrophizing among patients with PsA and may impact disease activity.

Discover how simple lifestyle changes — like exercise, diet, and better sleep — can help reduce symptoms and improve quality ...

I needed to find something that worked for both my psoriatic arthritis and my psoriasis because insurance would only cover the cost of one. It’s still hard for me to accept that treatment isn ...

Comorbidities, additional health conditions occurring alongside psoriatic arthritis, significantly impact treatment outcomes and quality of life. Common comorbidities include: Obesity, which ...

Dr. Ogdie: People with a lot of joint swelling tend to have an all-over pain that comes and goes, and typically, the pain improves with treatment of the psoriatic arthritis. But it can be ...

This variability contributes to delayed diagnosis, with many people enduring symptoms for years before receiving proper treatment. Left untreated, psoriatic arthritis can lead to permanent joint ...

Bimekizumab, as I mentioned, currently has FDA approval for psoriasis, but we are hoping to see that become available for psoriatic arthritis and axial spondyloarthritis, as well.

The main goal of psoriatic arthritis treatment is to control the inflammation that damages your joints and causes them to swell and ache. But your treatment will depend on several factors ...

with psoriatic arthritis (mean age, 48.2 years) who started advanced therapy between 2000 and 2023 was followed prospectively. Primary failure was defined as inefficacy during treatment or failure ...